Business
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions - CNBC
The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.
By: CNBC
- Dec 25 2024
- 0
- 0 Views
An injection pen of Zepbound, Eli Lillys weight loss drug, is displayed in New York City on Dec. 11, 2023.
The roughly $1,000 monthly price tag of Eli Lilly's weight loss drug Zepbound put the block… [+14923 chars]